BusinessAsianet Newsable
HIMS Stock Rises as FDA Appoints 8 New Peptide Advisors
in5points
HIMS stock snapped a 3-day losing streak.
FDA added 8 new peptide voters deemed more qualified and less conflicted.
New panelists bring expertise in neurology, pain, dermatology, gastroenterology, addiction, cancer pharmacology, and patient advocacy.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically